With markets at elevated ranges, I’m struggling to seek out a lot compelling worth for my Inventory and Shares ISA to date in July.
Nevertheless, I did purchase 4 totally different shares for my portfolio in June. Right here they’re and why I purchased them.
Digital labour
The primary was Salesforce (NYSE: CRM), whose cloud-based software program helps companies handle buyer relationships, gross sales, advertising and marketing, automation, and extra.
In its fiscal 2026 first quarter, the agency’s income jumped 8% to $9.8bn, permitting administration to lift its full-year steering by $400m to as a lot as $41.3bn. Nevertheless, it’s Salesforce’s development alternative with AI brokers that has attracted me.
An AI agent is sort of a digital worker that may autonomously perform duties. For instance, it could possibly be a buyer assist bot that solutions queries, or an HR assistant that schedules interviews and onboards employees. Or a gross sales agent that drafts emails to comply with up on leads.
Salesforce launched its digital labour platform Agentforce in late 2024. By the tip of April, it had already signed greater than 4,000 paid offers and 4,000 pilots. Blue-chip clients like Vans, PepsiCo, and Gucci are utilizing Agentforce for service, assist, and gross sales workflows.
Nevertheless, Salesforce inventory is down 19% this yr, which largely displays world financial dangers and uncertainties, significantly round tariffs. The agency additionally faces stiff competitors within the AI agent area from the likes of Microsoft.
That mentioned, Salesforce sees a possible $12trn alternative for digital labour. So there’s ample room for a number of winners on this market, particularly these with privileged entry to company-specific knowledge, like Salesforce.
The opposite three
I’ll point out two different development shares that I purchased in June, albeit briefly as a result of these stay smaller positions (for now).
The primary is Hims & Hers, which is a fast-growing digital platform that sells prescription and non-prescription well being merchandise. I invested after the inventory plunged 35% final month, following Novo Nordisk’s choice to finish its Wegovy cope with Hims & Hers.
Mainly, the corporate continues to promote “personalised” weight-loss remedies, which Novo describes as “knock-off” variations of its personal medicine. Hims & Hers denies any wrongdoing.
Admittedly, there are potential future authorized dangers right here, in addition to near-term stress on development. However Hims & Hers has a compelling long-term development alternative outdoors weight reduction, in areas like menopause, longevity, and psychological well being.
The second inventory I purchased was gaming platform Roblox. A number of months in the past, I agreed to purchase my seven-year-old daughter its digital forex Robux each time she progressed in her gymnastics class. Lo and behold, she’s all of the sudden flying — actually — by way of the degrees and it’s costing me a fortune!
Robux is used to unlock recreation options and improve avatars. In Q1, it helped gasoline a 31% surge in bookings, to a document $1.2bn.
The inventory’s price-to-sales ratio is 17. At this premium, the agency’s development wants to remain sturdy, or else. Nevertheless, with practically 100m day by day energetic customers, Roblox’s long-term monetisation potential from digital promoting has actually caught my consideration.
Lastly, I obtained a dividend from Authorized & Common in June. With the ahead yield at 8.8%, I used this money to purchase extra shares (dividend reinvesting).
Of those 4 shares, Salesforce stands out as one value traders’ consideration. It’s buying and selling at 23.8 instances ahead earnings, which seems engaging given the large alternative in AI brokers.
